Early trial tests new drug duo for weight loss
NCT ID NCT06924320
Summary
This early-stage study is testing the safety and effects of two experimental drugs, MET233 and MET097, given together as weekly injections. It aims to see if this combination helps adults with obesity or overweight lose weight, including some participants who also have type 2 diabetes. The main goal is to check for side effects and how the body processes the drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OBESITY-RELATED MEDICAL CONDITIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site MET233/097 24-101-001
RECRUITINGCypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.